SLITRK3 Activators
SLITRK3 Modulators encompasses various compounds that can indirectly influence the activity of SLITRK3, a protein implicated in neural development and synaptic function. These modulators do not directly activate SLITRK3 but rather affect related pathways and processes in the nervous system.
Calcium channel blockers like Nifedipine, GABA agonists such as Gabapentin, and glutamate receptor modulators including Memantine, play roles in modulating neuronal signaling and synaptic function. These compounds can influence the function of SLITRK3 in synaptic development and maintenance.Antidepressants, particularly SSRIs, affect synaptic plasticity and could have implications for SLITRK3-related pathways. Lithium, a mood stabilizer, has neuroprotective effects and might impact pathways involving SLITRK3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
These blockers can modulate neuronal signaling, potentially affecting SLITRK3-related synaptic functions. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
GABA agonists can modulate synaptic transmission, potentially impacting SLITRK3. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
These modulators can affect neuronal excitability and synaptic function, potentially influencing SLITRK3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Used in mood stabilization, lithium can affect neuroprotective pathways, possibly impacting SLITRK3. | ||||||
Prednisolone | 50-24-8 | sc-205815 sc-205815A | 1 g 5 g | $84.00 $253.00 | 2 | |
Corticosteroids can influence neuroinflammation and neural function, potentially affecting SLITRK3. | ||||||